LinkedIn Profile

Access xRAPID historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:xrapid 3765979 Jun 4th, 2019 12:00AM xRapid Foundation 197 1.00 Open Biotechnology Jun 4th, 2019 03:14PM Jun 4th, 2019 03:14PM xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease. By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market. The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease. xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster. Story: xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea. Open Health Technology, Malaria Diagnostics, Diagnostic Technology, Malaria Diagnostic App, Malaria, Smartphone Diagnosis, Malaria Blog, Digital Microscopy, Automated Malaria Diagnosis, Automated Digital Microscopy Open North Road London Greater London GB N79D
private:xrapid 3765979 Mar 18th, 2018 12:00AM xRapid-Medical 170 6.00 Open Biotechnology Mar 18th, 2018 06:41PM Mar 18th, 2018 06:41PM Open
private:xrapid 3765979 Feb 17th, 2018 12:00AM xRapid-Medical 166 9.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease. By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market. The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease. xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster. Story: xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
private:xrapid 3765979 Feb 16th, 2018 12:00AM xRapid-Medical 166 9.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease. By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market. The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease. xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster. Story: xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
private:xrapid 3765979 Feb 15th, 2018 12:00AM xRapid-Medical 166 9.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease. By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market. The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease. xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster. Story: xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
private:xrapid 3765979 Feb 14th, 2018 12:00AM xRapid-Medical 166 9.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease. By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market. The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease. xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster. Story: xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
private:xrapid 3765979 Feb 13th, 2018 12:00AM xRapid-Medical 166 9.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease. By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market. The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease. xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster. Story: xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
private:xrapid 3765979 Feb 12th, 2018 12:00AM xRapid-Medical 166 9.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease. By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market. The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease. xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster. Story: xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
private:xrapid 3765979 Feb 11th, 2018 12:00AM xRapid-Medical 166 9.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease. By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market. The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease. xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster. Story: xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.
private:xrapid 3765979 Feb 10th, 2018 12:00AM xRapid-Medical 166 9.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease. By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market. The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease. xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster. Story: xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.